BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Genetown

  In the Midst of Pandemic, Flagship Pioneering Raises $1.1 Billion for Biotech Startups

  Flagship began raising the funds in January, and closed on it late last week.

  April 2, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Biopharma Update on the Novel Coronavirus: April 2

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 2, 2020.

  April 2, 2020

   · 

  7 min read

   · 

  BioSpace Editorial Staff
• 

  Career Advice

  Follow-Up Communications that Keep You Top of Mind for Hiring Managers

  Once you’ve made initial meaningful contact with a hiring manager – through an interview, online or phone inquiry, informational interview or networking experience – the best way to turn that encounter into opportunity is through sustained follow-up.

  April 2, 2020

   · 

  9 min read

   · 

  Katharine Hansen, PhD
• 

  Policy

  Judge Denies Elizabeth Holmes’ Defense Team’s Request for Special Exemption Due to COVID-19

  On Wednesday, the judge overseeing Holmes’ case set for late July refused to change the trial date after her defense team made the request.

  April 2, 2020

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  After Failing to Gain FTC Approval, Sandoz and Aurobindo Call Off $1 Billion Deal

  Under terms of the deal, Aurobindo would pay $900 million upfront with an additional $100 million in milestone payments. However, in a filing with the Securities and Exchange Commission, the company announced it had terminated that agreement.

  April 2, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Pinpoint Therapeutics Targets COVID-19 With New Autophagy Pathway

  Pinpoint Therapeutics believes that its approach to treat therapy-resistant cancers also may be effective against COVID-19.

  April 2, 2020

   · 

  4 min read

   · 

  Gail Dutton
• 

  BioCapital

  Research Roundup: Analysis of the 1st U.S. Community-Transmitted COVID-19 Case and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  April 2, 2020

   · 

  5 min read

   · 

  Mark Terry
• 

  Business

  BioSpace Movers & Shakers, April 3

  Companies strengthen their leadership teams and executive boards with this week’s Movers & Shakers.

  April 2, 2020

   · 

  5 min read

   · 

  Alex Keown
• 

  Drug Development

  Merck’s Keytruda Hits Coprimary Endpoint Early in Colorectal Cancer Trial

  Keytruda (pembrolizumab) hit one of the coprimary endpoints early in the Phase III KEYNOTE-177 clinical trial for a highly mutating form of colorectal cancer.

  April 2, 2020

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Compare: 1918 Spanish Influenza Pandemic Versus COVID-19

  With all the similarities, it should be emphasized that there are several significant differences between the two pandemics.

  April 2, 2020

   · 

  9 min read

   · 

  Mark Terry